EIF5A and Hyperglycemia: Maier, et al. [29] reported that eIF5A depletion as well as the inhibition of hypusination protected against glucose intolerance in inflammatory mouse models of diabetes and that knockdown of eIF5A made mice resistant to β-cell loss and the development of hyperglycemia in the low-dose streptozotocin model of diabetes.